Immun4Cure Cohort of Autoimmune Diseases

Summary

This prospective cohort study aims to constitute a 500-participant database and biobank including 450 adults with systemic autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis) and 50 healthy controls.

Eligibility

Inclusion Criteria Participants:

Group 1: RA

* Adults ≥18 years
* Patient followed as part of their MAI in one of the departments participating in the study at UHM
* Confirmed diagnosis according to international criteria :ACR/EULAR 2010

Group 2: LES

* Adults ≥18 years
* Patient followed as part of their MAI in one of the departments participating in the study at UHM
* Confirmed diagnosis according to international criteria :ACR/EULAR 2019

Group 3: SSc

* Adults ≥18 years
* Patient followed as part of their MAI in one of the departments participating in the study at UHM
* Confirmed diagnosis according to international criteria :ACR/EULAR 2013

Group 4: Healthy Controls

* Adults ≥18 years
* No symptoms of autoimmune disease
* No first-degree family history of autoimmune disease

Exclusion Criteria (all groupes):

* Patients who have refused or are unable to give informed consent
* Inability to follow the subject during the study period
* Participation in another interventional study that includes an exclusion period that is still ongoing
* Pregnant women
* Not affiliated with a social security scheme
* Patients without a national insurance number
* Persons under judicial protection, guardianship or trusteeship
* Persons deprived of their liberty

Conditions7

Interventions2

Browse More Trials